From November 3–6, our team will join the global #ADC community at the 16th World ADC San Diego 2025 to exchange ideas, spark innovation, and shape the future of antibody-drug conjugates together with leading scientists, innovators, and industry experts.
Our Vice President, Chemistry and Early Discovery, @Marc-André Kasper, will share how we are leveraging our differentiated linker-payload chemistry to unlock novel payload classes and expand the therapeutic potential of ADCs, bringing these innovations closer to the clinic.
See the graphic below for details on Marc’s presentation.
Hope to see you in San Diego!
